Singapore markets closed

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
119.83-0.82 (-0.68%)
At close: 04:04PM EDT
120.00 +0.17 (+0.14%)
After hours: 04:49PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 24.65B
Enterprise value 30.59B
Trailing P/E 87.77
Forward P/E 17.95
PEG Ratio (5 yr expected) 4.04
Price/sales (ttm)3.13
Price/book (mrq)2.05
Enterprise value/revenue 3.87
Enterprise value/EBITDA 19.51

Trading information

Stock price history

Beta (5Y monthly) 1.16
52-week change 3-25.75%
S&P500 52-week change 3-1.04%
52-week high 3165.03
52-week low 3105.31
50-day moving average 3123.11
200-day moving average 3128.10

Share statistics

Avg vol (3-month) 31.57M
Avg vol (10-day) 3975.83k
Shares outstanding 5209.58M
Implied shares outstanding 6N/A
Float 8209.29M
% held by insiders 15.48%
% held by institutions 193.20%
Shares short (12 May 2022) 42.51M
Short ratio (12 May 2022) 41.68
Short % of float (12 May 2022) 41.34%
Short % of shares outstanding (12 May 2022) 41.20%
Shares short (prior month 13 Apr 2022) 43.28M

Dividends & splits

Forward annual dividend rate 40.96
Forward annual dividend yield 40.80%
Trailing annual dividend rate 30.96
Trailing annual dividend yield 30.80%
5-year average dividend yield 40.75
Payout ratio 471.64%
Dividend date 328 Jul 2022
Ex-dividend date 423 Jun 2022
Last split factor 2103:100
Last split date 328 Feb 2022

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 2.76%
Operating margin (ttm)16.47%

Management effectiveness

Return on assets (ttm)3.56%
Return on equity (ttm)2.31%

Income statement

Revenue (ttm)7.9B
Revenue per share (ttm)37.81
Quarterly revenue growth (yoy)3.90%
Gross profit (ttm)5.54B
EBITDA 2.37B
Net income avi to common (ttm)281.2M
Diluted EPS (ttm)1.04
Quarterly earnings growth (yoy)-92.80%

Balance sheet

Total cash (mrq)461.2M
Total cash per share (mrq)2.2
Total debt (mrq)6.38B
Total debt/equity (mrq)53.10
Current ratio (mrq)1.69
Book value per share (mrq)57.33

Cash flow statement

Operating cash flow (ttm)1.49B
Levered free cash flow (ttm)1.47B